(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one

C33H47BrO6Si — CID 52918513

IUPAC(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one
SMILESC=CC[C@@H]1C(=O)[C@H](Br)[C@]2(CO[Si](C)(C)C(C)(C)C)C[C@H]3[C@@H](OCc4ccccc4)[C@H]4OC(C)(C)O[C@@H]4[C@@H](C=C)[C@]13O2
InChIInChI=1S/C33H47BrO6Si/c1-10-15-23-25(35)29(34)32(20-37-41(8,9)30(3,4)5)18-24-26(36-19-21-16-13-12-14-17-21)28-27(38-31(6,7)39-28)22(11-2)33(23,24)40-32/h10-14,16-17,22-24,26-29H,1-2,15,18-20H2,3-9H3/t22-,23-,24+,26-,27-,28-,29+,32-,33+/m1/s1
InChIKeyBOZRDNBNHQIDEI-OIPRHVGOSA-N
MW647.72 g/mol
LogP6.98
Rot. Bonds9

About (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one

(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one (PubChem CID 52918513) has the molecular formula C33H47BrO6Si and a molecular weight of 647.72 g/mol. Its IUPAC name is (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one.

Molecular Properties

Compound Name(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one
PubChem CID52918513
Molecular FormulaC33H47BrO6Si
Molecular Weight647.72 g/mol
Exact Mass646.23
IUPAC Name(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one
SMILESC=CC[C@@H]1C(=O)[C@H](Br)[C@]2(CO[Si](C)(C)C(C)(C)C)C[C@H]3[C@@H](OCc4ccccc4)[C@H]4OC(C)(C)O[C@@H]4[C@@H](C=C)[C@]13O2
InChIInChI=1S/C33H47BrO6Si/c1-10-15-23-25(35)29(34)32(20-37-41(8,9)30(3,4)5)18-24-26(36-19-21-16-13-12-14-17-21)28-27(38-31(6,7)39-28)22(11-2)33(23,24)40-32/h10-14,16-17,22-24,26-29H,1-2,15,18-20H2,3-9H3/t22-,23-,24+,26-,27-,28-,29+,32-,33+/m1/s1
InChIKeyBOZRDNBNHQIDEI-OIPRHVGOSA-N
XLogP6.98
TPSA63.22 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500647.72
LogP ≤ 56.98
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one?
The IUPAC name of (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one (CID 52918513) is (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one.
What is the SMILES notation for (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one?
The canonical SMILES for (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one is C=CC[C@@H]1C(=O)[C@H](Br)[C@]2(CO[Si](C)(C)C(C)(C)C)C[C@H]3[C@@H](OCc4ccccc4)[C@H]4OC(C)(C)O[C@@H]4[C@@H](C=C)[C@]13O2.
What is the InChIKey of (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one?
The InChIKey is BOZRDNBNHQIDEI-OIPRHVGOSA-N. The full InChI is InChI=1S/C33H47BrO6Si/c1-10-15-23-25(35)29(34)32(20-37-41(8,9)30(3,4)5)18-24-26(36-19-21-16-13-12-14-17-21)28-27(38-31(6,7)39-28)22(11-2)33(23,24)40-32/h10-14,16-17,22-24,26-29H,1-2,15,18-20H2,3-9H3/t22-,23-,24+,26-,27-,28-,29+,32-,33+/m1/s1.
What are the key properties of (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one?
(1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one has a molecular weight of 647.72 g/mol, XLogP of 6.98, 9 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,3R,7R,8R,9S,11R,12R,14S)-12-bromo-11-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-ethenyl-5,5-dimethyl-8-phenylmethoxy-14-prop-2-enyl-4,6,15-trioxatetracyclo[9.3.1.01,9.03,7]pentadecan-13-one is sourced from PubChem (CID 52918513), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).